Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Kiromic BioPharma, Inc. (“Kiromic” or the “Company”) (NASDAQ: KRBP). Such investors are...
-
NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Quest Diagnostics Incorporated (“Quest” or the “Company”) (NYSE: DGX). Such investors are...
-
NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of MoneyLion Inc. (“MoneyLion” or the “Company”) (NYSE: ML). Such investors are advised to...
-
NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Natera, Inc. (“Natera” or the “Company”) (NASDAQ: NTRA). Such investors are advised to...
-
NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Yext, Inc. (“Yext” or the “Company”) (NYSE: YEXT). Such investors are advised to...
-
NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DiDi Global Inc. (“DiDi” or the “Company”) (NYSE: DIDI). Such investors are advised to...
-
NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NextEra Energy, Inc. (“NextEra” or the “Company”) (NYSE: NEE). Such investors are advised...
-
NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Finch Therapeutics Group, Inc. (“Finch” or the “Company”) (NASDAQ: FNCH). Such...
-
NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Beigene, Ltd. (“Beigene” or the “Company”) (NASDAQ: BGNE). Such investors are advised to...
-
NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ: ZLAB). Such investors are advised...